IL-1 receptor antagonist (IL-1Ra) is produced by isolated human hepatocytes with characteristics of an
acute-phase protein. There are multiple
IL-1Ra peptides, one secreted (sIL-1Ra) and three intracellular (icIL-1Ra1, 2, 3). sIL-1Ra, but not icIL-1Ra1,
mRNA is transcribed by cultured human hepatocytes. In this study, we examined in vivo production of
IL-1Ra by the liver in mice in two experimental models of
acute-phase response, systemic
lipopolysaccharide (LPS) administration and local
turpentine injection. Liver sIL-1Ra expression was up-regulated in response to both types of stimulation. After LPS injection, the hepatic production of sIL-1Ra correlated with the increase in plasma
IL-1Ra levels. In addition, the total amount of
IL-1Ra present in the liver after LPS injection was six- and tenfold higher than in the lung and spleen. As assessed by in situ hybridization, sIL-1Ra, but not icIL-1Ra,
mRNA was produced by hepatocytes in vivo after LPS injection. Using IL-6(-/-) mice, we demonstrated that in
turpentine-induced
inflammation production of
IL-1Ra mRNA by the liver is regulated by
IL-6. In contrast, local production of
IL-1Ra is independent of
IL-6. Taken together, these results indicate that
IL-1Ra is produced by the liver as an
acute-phase protein in vivo.